Full profile

Also known asCreatine, Creapure (branded)
Best forCognitive resilience under sleep loss or long high-output days · Low-baseline groups (vegetarian/vegan) · Stimulant-free brain-energy support
Evidence gradeGrade C — Limited — early or small human trials
Studied dose range3–5 g/day maintenance (standard). The sleep-deprivation study used a one-off ~0.35 g/kg dose, which is a research context, not a daily-use recommendation.
Time to effectDays to ~2–4 weeks to saturate brain and muscle stores at 3–5 g/day; no reliable acute everyday effect.
Best formCreatine monohydrate (Creapure-grade is a common quality marker). Other forms carry no proven advantage.
Food sourcesRed meat, Herring and salmon, Poultry (lower amounts)

Evidence, honestly graded

A systematic review (Avgerinos 2018, 6 RCTs / 281 people) found short-term memory and reasoning may improve, with effects concentrated in stressed or low-baseline states. A small crossover study (Gordji-Nejad 2024, n=15) found a single high dose improved cognition and sustained brain phosphocreatine during 21-hour sleep deprivation. In rested, well-fed adults the effect is small and inconsistent — honestly C, not an A/B cognition ingredient.

See the full grading rubric — study type, replication, population match, and dose adequacy — in The Evidence Standard.

Side effects

  • Minor water weight or initial GI upset
  • Loose stools if taken as one large dose
  • A benign rise in serum creatinine (a lab marker, not kidney damage)

Who should avoid it or check first

  • Pre-existing kidney disease without clinician oversight
  • Pregnant or breastfeeding without clinician guidance

Interactions

  • Can elevate measured serum creatinine — tell your clinician you supplement so kidney function is not misread
  • Use caution with nephrotoxic drugs — discuss with a clinician

Stacks well with

  • L-Theanine
  • Rhodiola Rosea
  • Omega-3 (EPA/DHA)

What to look for on a label

  • State creatine monohydrate in grams and note that a benign serum-creatinine rise is expected and is not kidney harm.
  • Health Canada's Creatine monograph is built around exercise/muscle/strength performance — there is no monograph cognition claim, so a brain/focus claim cannot ride the creatine monograph and would need its own evidence.

References

  • Avgerinos 2018, Exp Gerontol — systematic review. Modest memory/reasoning signal, strongest in stressed or low-baseline groups. PMID 29704637; doi:10.1016/j.exger.2018.04.013. Educational, not a product claim.
  • Gordji-Nejad 2024, Scientific Reports — sleep-deprivation crossover. Single high dose improved cognition and brain phosphocreatine during 21-hour sleep loss (n=15). doi:10.1038/s41598-024-54249-9. Educational.
  • Kreider 2017, J Int Soc Sports Nutr — ISSN safety position. Long-term safety review; no evidence of kidney harm in healthy people, plus the creatinine-marker caveat. PMID 28615996; doi:10.1186/s12970-017-0173-z.

Grades and studied doses are our conservative reading of the human research, shown for education. They are not product claims, and a studied dose is not a recommended dose.

See how Creatine Monohydrate compares on grade, dose, and goal in the Evidence Explorer.